SCHEMBL309668

SCHEMBL309668

CNS(=O)(=O)c1cccc(Nc2nc(N)ncc2C)c1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 20/20 0.61
BRAF P15056 8/20 0.57
EGFR P00533 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301265 0.87 JAK1 (0.60) TNNI3KBRAFEGFR
SCHEMBL29557228 0.87 TNNI3K (0.60) TNNI3KBRAFEGFR
SCHEMBL12279008 0.85 TNNI3K (0.57) TNNI3KBRAFEGFR
SCHEMBL10260824 0.83 BRD4 (0.57) TNNI3KBRAFEGFR
SCHEMBL302168 0.82 JAK3 (0.46) TNNI3KEGFR
SCHEMBL12320534 0.81 TNNI3K (0.53) TNNI3KEGFR
SCHEMBL10260435 0.81 GAK (0.55) TNNI3KBRAFEGFR
SCHEMBL270501 0.81 JAK1 (0.56) TNNI3KBRAFEGFR
SCHEMBL17915944 0.76 JAK3 (0.67) EGFR
SCHEMBL12111287 0.76 EGFR (0.50) BRAFEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133900-B2 Use of bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2012-03-13 US disclosed